top of page
WA.jpg

IN THE STATES

WASHINGTON

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Washington in 2022.

WA.png

Download vendor data for Washington:

Economic
Output

$26.7B

Direct Jobs Supported by the Industry

21,984

Total Jobs Supported

81,122

State Total Vendor Relationships

950

State Total Vendor Spending

$874,422,674

Clinical
Trials

847

Investments at Clinical Trial Sites

$295.7M

Clinical Trial Participants

25,267

Total Economic Impact of Clinical Trial Sites

$783.5M

bottom of page